SendaAjroud-DrissMD

PubMed

• Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts.
  Brannagan, T. H., Chafic Karam, Michelle L Mauermann, Alejandra Gonzalez-Duarte, Michelle C Kaku, Senda Ajroud-Driss, Thomas H Brannagan 3rd, Michael Polydefkis> ;Muscle & Nerve. 2024 Mar 1
• Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients.
  Perry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, Robert N Cole, Lauren R DeVine, Mazen M Dimachkie, Stefanie Geisler, Roy Freeman, David M Simpson, J Robinso...> ;Journal of the Peripheral Nervous System. 2024 Mar 1
• 6 citations
  Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.
  Laura Obici, Senda Ajroud-Driss, Kon-Ping Lin, John L Berk, Julian D Gillmore, Parag Kale, Haruki Koike, David Danese, Emre Aldinc, Chongshu Chen, John Vest, David Adams> ;Neurology and Therapy. 2023 Oct 1
• 1 citations
  The natural history of ALS: Baseline characteristics from a multicenter clinical cohort.
  Alex Berger, Matteo Locatelli, Ximena Arcila-Londono, Ghazala Hayat, Nicholas Olney, James Wymer, Kelly Gwathmey, Christian Lunetta, Terry Heiman-Patterson, Senda Ajro...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Jul 17
• Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
  Hiroshi Mitsumoto, Grace Jang, Ikjae Lee, Zachary Simmons, Alexander V Sherman, Daragh Heitzman, Eric Sorenson, Ken Cheung, Jinsy Andrews, Matthew Harms, Neil A Shneid...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Aug 1
• 2 citations
  CIDP prognosis in patients with IVIG treatment-related fluctuations.
  Mamatha Pasnoor, Senda Ajroud-Driss, Thomas H Brannagan, Mazen M Dimachkie, Jeffrey A Allen, Cook, M.> ;Muscle & Nerve. 2023 Jan 1
• 46 citations
  Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines.
  Emily G Baxi, Terri Thompson, Jonathan Li, Julia A Kaye, Ryan G Lim, Jie Wu, Divya Ramamoorthy, Leandro Lima, Vineet Vaibhav, Andrea Matlock, Aaron Frank, Alyssa N Coy...> ;Nature Neuroscience. 2022 Feb 1
• 4 citations
  Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study.
  Lauren Elman, Bora Youn, Crystal M Proud, Margaret R Frey, Senda Ajroud-Driss, M Eileen McCormick, David Michelson, Michael S Cartwright, Terry Heiman-Patterson, Josep...> ;Journal of Neuromuscular Diseases. 2022 Jan 1
• 5 citations
  An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
  Aaron S Zelikovich, Benjamin C Joslin, Patricia Casey, Elizabeth M McNally, Senda Ajroud-Driss> ;Journal of Neuromuscular Diseases. 2022 Jan 1
• 8 citations
  Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
  Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg, Valtteri V Aho, Toni Sarapohja, Mikko Kuoppamäki, Chris Garratt, Ammar Al...> ;The Lancet. Neurology. 2021 Oct 1
• 3 citations
  The accuracy of needle electrode placement by trainees in selected forearm muscles using verification by neuromuscular ultrasound.
  Tae Gun Jin, Dominic D'Andrea, Senda Ajroud-Driss, Colin K. Franz> ;Journal of Electromyography and Kinesiology. 2021 Oct 1
• 5 citations
  Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study
  Jeffrey A. Allen, Mamatha Pasnoor, Mazen M. Dimachkie, Senda Ajroud-Driss, Thomas H. Brannagan, Albert A. Cook, Timothy Walton, Mark Fiecas, John T. Kissel, Ingemar Me...> ;Neurology. 2021 Apr 6
• 69 citations
  Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
  David Adams, Michael Polydefkis, Alejandra González-Duarte, Jonas Wixner, Arnt V. Kristen, Hartmut Schmidt, John L. Berk, Inés Asunción Losada López, Angela Dispenzier...> ;The Lancet. Neurology. 2021 Jan 1
• 14 citations
  Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review
  Richard A. Lewis, David R. Cornblath, Hans-Peter Hartung, Gens Sobue, John-Philip Lawo, Orell Mielke, Billie L. Durn, Vera Bril, Ingemar S. J. Merkies, Paul Bassett, A...> ;Journal of the Peripheral Nervous System. 2020 Sep 1
• 23 citations
  Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy.
  Richard K. Burt, Roumen Balabanov, Jinny Tavee, Xiaoqiang Han, Robert L. Sufit, Senda Ajroud-Driss, Borko Jovanovic, Kathleen Quigley, Indira Arnautovic, Irene Helenow...> ;Journal of Neurology. 2020 Jun 27
• 8 citations
  ALS: Management Problems.
  Jonathan R Brent, Colin K. Franz, John M. Coleman, Senda Ajroud-Driss> ;Neurologic Clinics. 2020 Jun 11
• 24 citations
  DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.
  Delnaz Roshandel, Zhuo Chen, Angelo J. Canty, Shelley B. Bull, Rama Natarajan, Andrew D. Paterson, Stephen W. Scherer, F. Miao, L. Zhang, J. Brown-Friday, Jill P. Cran...> ;Clinical Epigenetics. 2020 Apr 5
• 41 citations
  Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
  Laura Obici, John L. Berk, Alejandra González-Duarte, Teresa Coelho, Julian D. Gillmore, Hartmut Schmidt, Matthias Schilling, Taro Yamashita, Céline Labeyrie, Thomas H...> ;Amyloid. 2020 Mar 4
• 16 citations
  Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort.
  Imen Kacem, Ikram Sghaier, Sabrine Bougatef, Amina Nasri, Amina Gargouri, Senda Ajroud-Driss, Riadh Gouider> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2020 Jan 2
• 1 citations
  Amyotrophic Lateral Sclerosis: Integrated care provides the best quality of life.
  Jonathan R Brent, Senda Ajroud-Driss> ;Practical Neurology. 2019 Jul 1
• 12 citations
  Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of...
  Orell Mielke, Vera Bril, David R. Cornblath, John-Philip Lawo, Nan van Geloven, Hans-Peter Hartung, Richard A. Lewis, Ingemar S. J. Merkies, Gen Sobue, Billie L. Durn,...> ;Journal of the Peripheral Nervous System. 2019 Mar 1
• 10 citations
  Peripheral Neuropathy Research Registry: A prospective cohort.
  Simone Thomas, Senda Ajroud-Driss, Mazen M. Dimachkie, Christopher H. Gibbons, Roy Freeman, David M. Simpson, J. Robinson Singleton, A. Gordon Smith, Ahmet Hoke> ;Journal of the Peripheral Nervous System. 2019 Mar 1
• 137 citations
  Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.
  Arnt V. Kristen, Senda Ajroud-Driss, Isabel Conceição, Peter D. Gorevic, Theodoros Kyriakides, Laura Obici> ;Neurodegenerative Disease Management. 2019 Feb 1
• New DEStiny Revealed: Young Woman Postablation for Wolf-Parkinson-White Syndrome With Recurrent Syncope and Progressive Myopathy.
  Gregory Aubert, Senda Ajroud-Driss, Bradley P. Knight, Sanjiv J. Shah, Elizabeth M. McNally> ;Circulation. 2018 Sep 18
• Intravenous versus subcutaneous immunoglobulin – Authors' reply
  Ivo N. van Schaik, Orell Mielke, Arman Sabet, Koshy George, Leslie Roberts, Ross Carne, Stefan Blum, Robert D. Henderson, Philip Van Damme, Jelle Demeestere, S. Larue,...> ;The Lancet. Neurology. 2018 May 1
• Join now to see all